Literature DB >> 7041664

Growth and development of two Trypanosoma cruzi clones in the arthropod Dipetalogaster maximus.

E S Garcia, J A Dvorak.   

Abstract

Trypomastigotes of single-cell-isolate Trypanosoma cruzi clones WA-250/1 and Esmereldo/2 were used to infect third-instar Dipetalogaster maximus. The level of infection was directly proportional to the concentration of trypomastigotes present in the blood meal. The minimum infectious dose for D. maximus was calculated as 5 organisms/ml. Clone WA-250/1 underwent epimastigote-to-metacylic trypomastigote transformation over the 30-day course of the experiments; clone Esmeraldo/2 did not undergo transformation to metacylic trypomastigotes. These data extend our knowledge of the biological diversity of T. cruzi stocks.

Entities:  

Mesh:

Year:  1982        PMID: 7041664     DOI: 10.4269/ajtmh.1982.31.259

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  4 in total

1.  Scanning electron microscopic studies of Trypanosoma cruzi in the rectum of its vector Triatoma infestans.

Authors:  C A Böker; G A Schaub
Journal:  Z Parasitenkd       Date:  1984

2.  Are Members of the Triatoma brasiliensis (Hemiptera, Reduviidae) Species Complex Able to Alter the Biology and Virulence of a Trypanosoma cruzi Strain?

Authors:  J Costa; C A C Araújo; C A V Freitas; J Borges-Pereira
Journal:  Neotrop Entomol       Date:  2015-03-03       Impact factor: 1.434

3.  Natural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure.

Authors:  M Tibayrenc; P Ward; A Moya; F J Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

4.  Proliferation and differentiation of Trypanosoma cruzi inside its vector have a new trigger: redox status.

Authors:  Natália P Nogueira; Francis M S Saraiva; Pedro E Sultano; Paula R B B Cunha; Gustavo A T Laranja; Graça A Justo; Kátia C C Sabino; Marsen G P Coelho; Ana Rossini; Georgia C Atella; Marcia C Paes
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.